IP Library Granted Patent US 9,896,696
Granted Patent B2
US 9,896,696 · App. 15/432,109 · Granted Feb 20, 2018

Compositions and methods for modifying genomes

Inventors: Matthew Begemann (St. Louis, MO); Benjamin Neil Gray (Chapel Hill, NC)
Assignee: Benson Hill Biosystems, Inc.
C12N15/8274C12N9/22C12N15/102C12N15/62C12N15/8202C12N15/8213
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,896,696
App. No.
15/432,109
Granted
Feb 20, 2018
Kind
B2
Abstract

Compositions and methods for modifying genomic DNA sequences are provided. The methods produce double-stranded breaks (DSBs) at pre-determined target sites in a genomic DNA sequence, resulting in mutation, insertion, and/or deletion of DNA sequences at the target site(s) in a genome. Compositions comprise DNA constructs comprising nucleotide sequences that encode a Cpf1 or Csm1 protein operably linked to a promoter that is operable in the cells of interest. The DNA constructs can be used to direct the modification of genomic DNA at pre-determined genomic loci. Methods to use these DNA constructs to modify genomic DNA sequences are described herein. Additionally, compositions and methods for modulating the expression of genes are provided. Compositions comprise DNA constructs comprising a promoter that is operable in the cells of interest operably linked to nucleotide sequences that encode a mutated Cpf1 or Csm1 protein with an abolished ability to produce DSBs, optionally linked to a domain that regulates transcriptional activity. The methods can be used to up- or down-regulate the expression of genes at predetermined genomic loci.

Claims (33)

1. A method of modifying a nucleotide sequence at a target site in the genome of a eukaryotic cell comprising:

introducing into said eukaryotic cell

(i) a DNA-targeting RNA, or a DNA polynucleotide encoding a DNA-targeting RNA, wherein the DNA-targeting RNA comprises: (a) a first segment comprising a nucleotide sequence that is complementary to a sequence in the target DNA; and (b) a second segment that interacts with a Csm1 polypeptide; and

(ii) a Csm1 polypeptide, or a polynucleotide encoding a Csm1 polypeptide, wherein the Csm1 polypeptide comprises: (a) an RNA-binding portion that interacts with the DNA-targeting RNA; and (b) an activity portion that exhibits site-directed enzymatic activity,

wherein said Csm1 polypeptide has at least 95% identity with a sequence selected from the group consisting of: SEQ ID NOs: 134, 147, 160, and 230, and has Csm1 nuclease activity, wherein said method modifies said nucleotide sequence at said target site, and wherein said genome of a eukaryotic cell is a nuclear, plastid, or mitochondrial genome.

2. A method of modifying a nucleotide sequence at a target site in the genome of a prokaryotic cell comprising:

introducing into said prokaryotic cell

(i) a DNA-targeting RNA, or a DNA polynucleotide encoding a DNA-targeting RNA, wherein the DNA-targeting RNA comprises: (a) a first segment comprising a nucleotide sequence that is complementary to a sequence in the target DNA; and (b) a second segment that interacts with a Csm1 polypeptide; and

(ii) a Csm1 polypeptide, or a polynucleotide encoding a Csm1 polypeptide, wherein the Csm1 polypeptide comprises: (a) an RNA-binding portion that interacts with the DNA-targeting RNA; and (b) an activity portion that exhibits site-directed enzymatic activity,

wherein said Csm1 polypeptide has at least 95% identity with a sequence selected from the group consisting of: SEQ ID NOs: 134, 147, 160, and 230 and has Csm1 nuclease activity, wherein said method modifies said nucleotide sequence at said target site, wherein said genome of a prokaryotic cell is a chromosomal, plasmid, or other intracellular DNA sequence, and wherein said prokaryotic cell is not the natural host of a gene encoding said Csm1 polypeptide.

3. The method of claim 1 wherein said eukaryotic cell is a plant cell.

4. The method of claim 3 , further comprising:

culturing the plant cell to produce a plant under conditions in which the Csm1 polypeptide is expressed and cleaves the nucleotide sequence at the target site to produce a modified nucleotide sequence; and selecting a plant comprising said modified nucleotide sequence.

5. The method of claim 1 , wherein said Csm1 polypeptide comprises a sequence selected from the group consisting of SEQ ID NOs: 134, 147, 160, and 230.

6. The method of claim 2 , wherein said Csm1 polypeptide comprises a sequence selected from the group consisting of SEQ ID NOs: 134, 147, 160, and 230.

7. The method of claim 1 , wherein said modified nucleotide sequence comprises insertion of heterologous DNA into the genome of the cell, deletion of a nucleotide sequence from the genome of the cell, or mutation of at least one nucleotide in the genome of the cell.

8. The method of claim 2 , wherein said modified nucleotide sequence comprises insertion of heterologous DNA into the genome of the cell, deletion of a nucleotide sequence from the genome of the cell, or mutation of at least one nucleotide in the genome of the cell.

9. The method of claim 1 wherein said modified nucleotide sequence comprises insertion of a polynucleotide that encodes a protein conferring antibiotic or herbicide tolerance to transformed cells.

10. The method of claim 9 wherein said polynucleotide that encodes a protein conferring antibiotic or herbicide tolerance comprises SEQ ID NO:76, or encodes a protein that comprises SEQ ID NO:77.

11. A nucleic acid molecule comprising a polynucleotide sequence encoding a Csm1 polypeptide, wherein said polynucleotide sequence has at least 95% identity with a sequence selected from the group consisting of SEQ ID NOs: 185, 186, and 193, or a fragment or variant thereof, or wherein said polynucleotide sequence encodes a Csm1 polypeptide with at least 95% identity to a sequence selected from the group consisting of SEQ ID NOs: 134, 147, 160, and 230 and has Csm1 nuclease activity, and wherein said polynucleotide sequence encoding a Csm1 polypeptide is operably linked to a promoter that is heterologous to the polynucleotide sequence encoding a Csm1 polypeptide.

12. The nucleic acid molecule of claim 11 wherein said nucleic acid molecule comprising a polynucleotide sequence encoding a Csm1 polypeptide comprises a sequence selected from the group consisting of SEQ ID NOs: 185, 186, and 193, or encodes a Csm1 polypeptide that comprises a sequence selected from the group consisting of SEQ ID NOs: 134, 147, 160, and 230.

13. A Csm1 polypeptide encoded by the nucleic acid molecule of claim 11 .

14. A plant cell, eukaryotic cell, or prokaryotic cell comprising the nucleic acid molecule of claim 11 .

15. A plant cell, eukaryotic cell, or prokaryotic cell comprising the nucleic acid molecule of claim 12 .

16. A eukaryotic cell produced by the method of claim 1 .

17. The eukaryotic cell of claim 16 wherein said eukaryotic cell is a plant cell.

18. A plant comprising the nucleic acid molecule of claim 11 .

19. A plant comprising the nucleic acid molecule of claim 12 .

20. A plant produced by the method of claim 3 .

21. The seed of the plant of claim 18 .

22. The seed of the plant of claim 20 .

23. The nucleic acid molecule of claim 11 wherein said polynucleotide sequence encoding a Csm1 polypeptide is codon-optimized for expression in a plant cell.

24. The method of claim 3 wherein said polynucleotide encoding a Csm1 polypeptide is codon-optimized for expression in a plant cell.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2025
From: BENSON HILL, INC.; BENSON HILL HOLDINGS, INC.; BENSON HILL FRESH, LLC; BENSON HILL SEEDS HOLDING, INC.; BHB HOLDINGS, LLC; J&J SOUTHERN FARMS, INC.; BENSON HILL SEEDS, INC.
To: CONFLUENCE GENETICS, LLC
Reel/Frame 071578/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2025
From: BENSON HILL, INC.; BENSON HILL HOLDINGS, INC.; BENSON HILL FRESH, LLC; BENSON HILL SEEDS HOLDING, INC.; BENSON HILL SEEDS, INC.; BHB HOLDINGS, LLC; J&J SOUTHERN FARMS, LLC
To: CONFLUENCE GENETICS, LLC
Reel/Frame 071982/0368 →
RELEASE OF SECURITY INTEREST Recorded Feb 14, 2024
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: BENSON HILL HOLDINGS, INC.
Reel/Frame 066460/0961 →
RELEASE OF SECURITY INTEREST Recorded Jan 3, 2024
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: BENSON HILL, INC.
Reel/Frame 066002/0450 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2023
From: BENSON HILL HOLDINGS, INC.
To: RICETEC, INC.
Reel/Frame 065500/0091 →
CHANGE OF NAME Recorded Sep 29, 2023
From: BENSON HILL, INC.
To: BENSON HILL HOLDINGS, INC.
Reel/Frame 065076/0971 →
CHANGE OF NAME Recorded Sep 29, 2023
From: BENSON HILL BIOSYSTEMS, INC.
To: BENSON HILL, INC.
Reel/Frame 065086/0281 →
SECURITY INTEREST Recorded Jan 18, 2023
From: BENSON HILL, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
Reel/Frame 062404/0643 →
RELEASE OF SECURITY INTEREST Recorded Oct 4, 2021
From: VENTURE LENDING & LEASING VIII, INC.; VENTURE LENDING & LEASING IX, INC.
To: BENSON HILL, INC.
Reel/Frame 057696/0136 →
SECURITY INTEREST Recorded Feb 5, 2020
From: BENSON HILL, INC.
To: VENTURE LENDING & LEASING VIII, INC.; VENTURE LENDING & LEASING IX, INC.
Reel/Frame 051830/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2017
From: BEGEMANN, MATTHEW; GRAY, BENJAMIN NEIL
To: BENSON HILL BIOSYSTEMS, INC.
Reel/Frame 041536/0147 →
Continuity (6)
Provisional Application 62295325 · Feb 15, 2016
Provisional Application 62372108 · Aug 8, 2016
Provisional Application 62403854 · Oct 4, 2016
Provisional Application 62429112 · Dec 2, 2016
Provisional Application 62450743 · Jan 26, 2017
Related Publication 20170233756A1 · Aug 17, 2017